ANTERIS TECHNOLOGIES GLOBAL (AVR) Fundamental Analysis & Valuation

NASDAQ:AVRUS03675P1021

Current stock price

5.19 USD
-0.2 (-3.71%)
At close:
5.19 USD
0 (0%)
After Hours:

This AVR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AVR Profitability Analysis

1.1 Basic Checks

  • AVR had negative earnings in the past year.
  • AVR had a negative operating cash flow in the past year.
AVR Yearly Net Income VS EBIT VS OCF VS FCFAVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of AVR (-409.38%) is worse than 94.18% of its industry peers.
Industry RankSector Rank
ROA -409.38%
ROE N/A
ROIC N/A
ROA(3y)-218.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVR Yearly ROA, ROE, ROICAVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 20K 40K 60K 80K 100K

1.3 Margins

  • AVR's Gross Margin of 70.26% is fine compared to the rest of the industry. AVR outperforms 79.89% of its industry peers.
  • AVR's Gross Margin has improved in the last couple of years.
  • AVR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y96.05%
GM growth 5YN/A
AVR Yearly Profit, Operating, Gross MarginsAVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -1K -2K -3K -4K

0

2. AVR Health Analysis

2.1 Basic Checks

  • AVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for AVR has been increased compared to 1 year ago.
  • AVR has a worse debt/assets ratio than last year.
AVR Yearly Shares OutstandingAVR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M 40M
AVR Yearly Total Debt VS Total AssetsAVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of -22.63, we must say that AVR is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of AVR (-22.63) is worse than 89.95% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -22.63
ROIC/WACCN/A
WACC10.7%
AVR Yearly LT Debt VS Equity VS FCFAVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 50M -50M

2.3 Liquidity

  • AVR has a Current Ratio of 0.73. This is a bad value and indicates that AVR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.73, AVR is not doing good in the industry: 89.42% of the companies in the same industry are doing better.
  • AVR has a Quick Ratio of 0.73. This is a bad value and indicates that AVR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AVR's Quick ratio of 0.73 is on the low side compared to the rest of the industry. AVR is outperformed by 84.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.73
AVR Yearly Current Assets VS Current LiabilitesAVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 20M 40M 60M

4

3. AVR Growth Analysis

3.1 Past

  • AVR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -20.15%.
  • Looking at the last year, AVR shows a very negative growth in Revenue. The Revenue has decreased by -29.23% in the last year.
  • AVR shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -15.77% yearly.
EPS 1Y (TTM)-20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.87%
Revenue 1Y (TTM)-29.23%
Revenue growth 3Y-15.77%
Revenue growth 5YN/A
Sales Q2Q%-42.17%

3.2 Future

  • Based on estimates for the next years, AVR will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.72% on average per year.
  • AVR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 196.22% yearly.
EPS Next Y52.47%
EPS Next 2Y25.78%
EPS Next 3Y16.72%
EPS Next 5YN/A
Revenue Next Year251.67%
Revenue Next 2Y129.79%
Revenue Next 3Y94.93%
Revenue Next 5Y196.22%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AVR Yearly Revenue VS EstimatesAVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
AVR Yearly EPS VS EstimatesAVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

0

4. AVR Valuation Analysis

4.1 Price/Earnings Ratio

  • AVR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVR Price Earnings VS Forward Price EarningsAVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVR Per share dataAVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2 -2.5

4.3 Compensation for Growth

  • AVR's earnings are expected to grow with 16.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.78%
EPS Next 3Y16.72%

0

5. AVR Dividend Analysis

5.1 Amount

  • No dividends for AVR!.
Industry RankSector Rank
Dividend Yield 0%

AVR Fundamentals: All Metrics, Ratios and Statistics

ANTERIS TECHNOLOGIES GLOBAL

NASDAQ:AVR (3/27/2026, 8:01:38 PM)

After market: 5.19 0 (0%)

5.19

-0.2 (-3.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-26
Earnings (Next)05-11
Inst Owners31.45%
Inst Owner Change-8.84%
Ins Owners0.41%
Ins Owner Change78.07%
Market Cap504.62M
Revenue(TTM)1.91M
Net Income(TTM)-94.14M
Analysts80
Price Target16.32 (214.45%)
Short Float %2.76%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.47%
Min EPS beat(2)-24.18%
Max EPS beat(2)-6.76%
EPS beat(4)0
Avg EPS beat(4)-16.55%
Min EPS beat(4)-27.6%
Max EPS beat(4)-6.76%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)29.83%
Min Revenue beat(2)6.19%
Max Revenue beat(2)53.47%
Revenue beat(4)4
Avg Revenue beat(4)25%
Min Revenue beat(4)6.19%
Max Revenue beat(4)53.47%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.67%
PT rev (3m)-3.03%
EPS NQ rev (1m)48.15%
EPS NQ rev (3m)48.15%
EPS NY rev (1m)0%
EPS NY rev (3m)32.77%
Revenue NQ rev (1m)-19.98%
Revenue NQ rev (3m)-19.98%
Revenue NY rev (1m)-21.85%
Revenue NY rev (3m)-21.85%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 263.79
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.55
EYN/A
EPS(NY)-1.21
Fwd EYN/A
FCF(TTM)-0.82
FCFYN/A
OCF(TTM)-0.8
OCFYN/A
SpS0.02
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -409.38%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.26%
FCFM N/A
ROA(3y)-218.22%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y96.05%
GM growth 5YN/A
F-Score3
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 117.64%
Cap/Sales 102.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.73
Quick Ratio 0.73
Altman-Z -22.63
F-Score3
WACC10.7%
ROIC/WACCN/A
Cap/Depr(3y)158.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)91.36%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.87%
EPS Next Y52.47%
EPS Next 2Y25.78%
EPS Next 3Y16.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-29.23%
Revenue growth 3Y-15.77%
Revenue growth 5YN/A
Sales Q2Q%-42.17%
Revenue Next Year251.67%
Revenue Next 2Y129.79%
Revenue Next 3Y94.93%
Revenue Next 5Y196.22%
EBIT growth 1Y-19.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.19%
EBIT Next 3Y7.2%
EBIT Next 5Y28.78%
FCF growth 1Y-25.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.04%
OCF growth 3YN/A
OCF growth 5YN/A

ANTERIS TECHNOLOGIES GLOBAL / AVR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ANTERIS TECHNOLOGIES GLOBAL (AVR) stock?

ChartMill assigns a fundamental rating of 1 / 10 to AVR.


Can you provide the valuation status for ANTERIS TECHNOLOGIES GLOBAL?

ChartMill assigns a valuation rating of 0 / 10 to ANTERIS TECHNOLOGIES GLOBAL (AVR). This can be considered as Overvalued.


What is the profitability of AVR stock?

ANTERIS TECHNOLOGIES GLOBAL (AVR) has a profitability rating of 1 / 10.


What is the earnings growth outlook for ANTERIS TECHNOLOGIES GLOBAL?

The Earnings per Share (EPS) of ANTERIS TECHNOLOGIES GLOBAL (AVR) is expected to grow by 52.47% in the next year.